Laurus Labs Limited Laurus Labs Limited

Laurus Labs Limited

LAURUSLABS

Rang in Aktien #1741
Established in 2005 and headquartered in Hyderabad, India, Laurus Labs Limited,... Established in 2005 and headquartered in Hyderabad, India, Laurus Labs Limited, along with its subsidiaries, operates as a diversified global pharmaceutical company. It focuses on the research, manufacturing, and international distribution of a broad spectrum of medicines and active pharmaceutical ingredients (APIs). The company's API and advanced intermediate offerings cover key therapeutic domains such as anti-retroviral (ARV), antidiabetic, cardiovascular, proton pump inhibitors (PPIs), oncology, gastroenterology, and hepatitis C. Additionally, Laurus Labs develops and produces oral solid dosage forms targeting ARV, antidiabetic, cardiovascular, PPI, and central nervous system (CNS) conditions. Beyond its proprietary products, the firm extends its expertise through contract development and manufacturing services for other pharmaceutical enterprises. It also supplies specialized ingredients vital for nutraceutical, dietary supplement, and cosmeceutical applications. Furthermore, Laurus Labs is at the forefront of innovation, engineering novel enzymatic solutions for industrial biotechnology, and providing animal-origin-free recombinant proteins and enzymes for biopharmaceutical use, alongside offering a range of business support services within the pharmaceutical industry.
Aktienkurs
$22.83
Zuletzt synchronisiert: 2026-10-19
Marktkapitalisierung
$12.34B
Veränderung (1 Tag)
0.51%
Veränderung (1 Jahr)
117.95%
Land
IN
Handel Laurus Labs Limited (LAURUSLABS)

Kategorie

Healthcare
Aktien-Split-Historie für Laurus Labs Limited (LAURUSLABS)
Die Aktie Laurus Labs Limited (Symbol: LAURUSLABS) durchlief insgesamt 1 Aktiensplits.
Der letzte Aktiensplit fand am Sep 29, 2020 statt.
Eine LAURUSLABS-Aktie, die vor dem Sep 29, 2020 gekauft wurde, entspricht heute 5 LAURUSLABS-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
2020-09-29 5:1 x5 x5
Aktiensplits ähnlicher Unternehmen oder Wettbewerber